Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT00185744
NA

Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

Sponsor: Stanford University

View on ClinicalTrials.gov

Summary

To determine whether an accelerated course of radiotherapy delivered to the lumpectomy cavity plus margin using IORT as a single dose, intracavitary brachytherapy with the MammoSite device over 5 days, partial breast 3-D CRT in 5 days, or stereotactic APBI over 4 days is a feasible and safe alternative to a six and a half week course of whole breast radiotherapy. The study will measure both short and long-term complications of radiation treatment, short and long-term breast cosmesis, local rates of in-breast cancer recurrence, regional recurrences, distant metastases, and overall survival.

Key Details

Gender

FEMALE

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

121

Start Date

2002-09

Completion Date

2029-03

Last Updated

2026-03-20

Healthy Volunteers

No

Interventions

RADIATION

Intra-Operative Radiotherapy (IORT)

single dose in the operating room after lumpectomy

PROCEDURE

Lumpectomy

RADIATION

Whole Breast Radiotherapy

six and a half week treatment

RADIATION

Intracavitary Brachytherapy

5 day treatment

RADIATION

Accelerated External Beam 3-D Conformal Radiotherapy

5 day treatment

RADIATION

Stereotactic APBI

4 day treatment

Locations (1)

Stanford University School of Medicine

Stanford, California, United States